tiprankstipranks
IO Biotech (IOBT)
NASDAQ:IOBT
US Market

IO Biotech (IOBT) Financial Statements

176 Followers

IO Biotech Financial Overview

IO Biotech's market cap is currently ―. The company's EPS TTM is $-1.859; its P/E ratio is -0.72; IO Biotech is scheduled to report earnings on August 9, 2024, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -19.04M$ -25.83M$ -22.12M$ -20.65M$ -16.64M
EBITDA$ -18.83M$ -25.63M$ -21.92M$ -20.46M$ -16.46M
Net Income Common Stockholders$ -19.46M$ -26.18M$ -21.68M$ -21.18M$ -17.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 117.98M$ 143.19M$ 165.50M$ 110.09M$ 128.53M
Total Assets$ 128.16M$ 150.72M$ 172.55M$ 117.56M$ 136.00M
Total Debt$ 2.32M$ 2.49M$ 2.60M$ 2.77M$ 2.83M
Net Debt$ -115.67M$ -140.70M$ -162.90M$ -107.32M$ -125.70M
Total Liabilities$ 12.69M$ 17.56M$ 14.96M$ 13.04M$ 12.63M
Stockholders Equity$ 115.47M$ 133.16M$ 157.59M$ 104.52M$ 124.22M
Cash Flow-
Free Cash Flow$ -24.94M$ -22.91M$ -16.01M$ -18.30M$ -14.84M
Operating Cash Flow$ -24.93M$ -22.80M$ -15.99M$ -18.26M$ -14.69M
Investing Cash Flow$ -11.00K$ -112.00K$ -24.00K$ -39.00K$ -148.00K
Financing Cash Flow-$ -10.00K$ 71.87M--
Currency in USD

IO Biotech Earnings and Revenue History

IO Biotech Debt to Assets

IO Biotech Cash Flow

IO Biotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis